Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
M3 Inc (2413 JP)
Watchlist
162
Analysis
Health Care
•
Japan
M3, Inc. supplies medical information services for doctors through the Internet. The Company also supports marketing of pharmaceutical companies and medical equipment manufacturers.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
22 Feb 2021 12:16
🇯🇵 JAPAN • IT’S A WRAP - Winter 2020 Results & Revisions Review
NET GAIN - Forecast Aggregate Net Income for the universe of Japanese listed companies ended the quarter 23.8% higher than three months ago - an...
Campbell Gunn
Follow
370 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Feb 2021 07:02
🇯🇵 JAPAN • The Post-COVID Rotation from Growth to Value Begins + 02/05 Results & Revisions Update
THE 2021 ROTATION BEGINS - For most of the last year, the Japanese equity market has been led by overvalued and overbought high-quality growth...
Campbell Gunn
Follow
318 Views
Share
bearish
•
Thematic (Sector/Industry)
•
22 Jan 2021 13:00
🇯🇵 JAPAN • January Relative Price Scores - Actionable Mean Reversion Trades
As the Japanese equity market continues to rise the 'spread' between the percentage of listed companies that are OverSold and those that are...
Campbell Gunn
Follow
571 Views
Share
bullish
•
CyberAgent Inc
•
11 Jan 2021 16:37
Japan Governance - Diversity Matters
Japanese companies have very low levels of board diversity. Participation by women is too low to see any tangible results yet, but more youthful...
Mark Chadwick
Follow
381 Views
Share
bearish
•
Japan Airlines
•
30 Jun 2026 19:09
MS-Japan June 2026 Rebalance: Post-Implementation Review
MSCI Japan June 2026 rebalance has passed the first post-implementation week. We review what worked, what did not, and how current results compare...
Ke Yan, CFA, FRM
Follow
154 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x